Coloplast Danmark A/S

A/SActive

CVR 19020940Holtedam 1, 3050 HumlebækWholesale of pharmaceutical and medical goods· NACE 4646Est. 1995 · 30 years old71 employees

Overview

Coloplast Danmark A/S is a Danish A/S based in Humlebæk, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 1995, the company has 71 employees and reported a gross profit of DKK 107.8m in its latest annual filing.

Gross profit 2025

107.8M DKK

+11% vs 2024

EBITDA margin (of gross profit)

35.8 %

+39% vs 2024

Net profit 2025

30.8M DKK

+35% vs 2024

Key ratios

See full ratios →

56.4 %

Strong

Among the 40% highest rated companies in the industry

20212025

4.4×

Very strong

Among the 20% highest rated companies in the industry

20212025

41.6 %

Very strong

Among the 10% highest rated companies in the industry

20212025

EBITDA — year on year

DKK millions

Key figures

Annual report 2025

Gross profit	107.8M DKK	+11%
EBITDA	38.6M DKK	+39%
Net profit	30.8M DKK	+35%
Total assets	74M DKK	-5%
Equity	41.7M DKK	+27%
Employees	71	—

Financial development

In its most recent annual report (2025), Coloplast Danmark A/S reported a gross profit of DKK 107.8m, an increase of 11% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 30.8m, and the EBITDA margin stood at 35.8%.

At the end of 2025, equity financed 56.4% of the balance sheet, and current assets covered short-term debt 4.4 times.

Financials

Gross profit

DKK millions

EBITDA

DKK millions

Income statement

DKK thousands

Item	2025	2024	2023	2022	2021
Gross profit	107,809	97,098	102,930	88,520	70,684
Staff expenses	-0	-0	-0	-0	-0
EBITDA	38,579	27,743	38,797	29,200	17,636
Depreciation & amort.	-0	-0	-0	-0	-0
EBIT	38,579	27,743	38,797	29,200	17,636
Net financials	1,000	1,713	1,125	11	11
Profit before tax	39,579	29,456	39,922	29,211	17,647
Tax	8,819	6,654	8,896	6,559	3,968
Net profit	30,760	22,802	31,026	22,652	13,679

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2025	2024	2023	2022	2021
Total assets	73,992	77,787	83,183	78,465	54,353
Equity	41,728	32,968	41,166	33,140	23,488
Long-term debt	4,642	6,873	6,719	0	0
Short-term debt	16,696	23,559	21,921	22,074	18,347
Total debt	21,338	30,432	28,640	22,074	30,865

Financial ratios

5-year trend

EBITDA margin (of gross profit)

35.8 %

20212025

Equity ratio

56.4 %

Strong

Among the 40% highest rated companies in the industry

20212025

Return on equity

73.7 %

Very strong

Among the 10% highest rated companies in the industry

20212025

Net profit margin (of gross profit)

28.5 %

20212025

Asset turnover (of gross profit)

1.46×

20212025

Debt / equity

0.77×

Strong

Among the 40% highest rated companies in the industry

20212025

Sector performance

23 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on equity (ROE)Very strong

Among the 10% highest rated companies in the industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Very strong

Among the 10% highest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Very strong

Among the 20% highest rated companies in the industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Very strong

Among the 10% highest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Capacity ratioStrong

Among the 30% highest rated companies in the industry

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Liquidity

Current ratioVery strong

Among the 20% highest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioVery strong

Among the 20% highest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioVery weak

Among the 10% lowest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityAverage

Around the average of companies in the same industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalVery strong

Among the 10% highest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioAverage

Around the average of companies in the same industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Debt & solvency

Solidity ratioStrong

Among the 40% highest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioStrong

Among the 30% highest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityStrong

Among the 40% highest rated companies in the industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityAverage

Around the average of companies in the same industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtVery strong

Among the 10% highest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtVery strong

Among the 10% highest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery strong

Among the 10% highest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtStrong

Among the 30% highest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery strong

Among the 10% highest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Equity to contributed capitalVery strong

Among the 10% highest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityStrong

Among the 30% highest rated companies in the industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtVery strong

Among the 20% highest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30

People & ownership

Management

Actively employed in the business

No data on file.

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

Coloplast A/S100%

Coloplast Danmark A/S (this company)

Frequently asked questions

What is the CVR number of Coloplast Danmark A/S?

Coloplast Danmark A/S is registered with CVR / Virk under CVR 19020940.

What is the gross profit of Coloplast Danmark A/S?

Coloplast Danmark A/S reported a gross profit of DKK 107.8m in 2025.

How many employees does Coloplast Danmark A/S have?

Coloplast Danmark A/S employs 71 people as of the latest annual report.

Where is Coloplast Danmark A/S headquartered?

Coloplast Danmark A/S's registered address is Holtedam 1.